Why GRAL? GRAIL, Inc. Analysis, Price & AI Insights | Whystock
GRAL
$54.06-0.42 (-0.77%)
Market ClosedLast close May 1
GRAIL, Inc., a commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.